🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Early Visual Functions in Patients at Risk of Developing Cerebral Visual Impairment. A Pilot Study

Recruitingn/aAges 2 Days - 36 MonthsAllFondazione Policlinico Universitario Agostino Gem…
NCT05865093 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of the study is to assess visual function from neonatal age to 36 months of age in infants at risk of visual impairment due to brain lesion or ocular pathology

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age between 34 weeks of post-menstrual age and 36 months of life in children born before 37 weeks gestational age * Genetic syndroms * Hypoxic Hischemic Encephalopathy * Brain malformation * Metabolic diseases * Ocular pathologies Exclusion Criteria: * Patients at low risk of developing neurological outcomes * Refusal of informed consent
💊

What it tests

  • Not listed
📍

Where

1 site
Fondazione Policlinico Gemelli
Rome, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy